The Innovation and Value Initiative (IVI) is pleased to announce the completion of its 4th Annual Meeting, our second in-person meeting since the pandemic. We were thrilled to see our esteemed members, partners, and colleagues participate in many important discussions. This year, we featured multiple IVI research initiatives, including the IVI Major Depressive Disorder (IVI-MDD) [...]
Alexandria, VA – September 28, 2023 – The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of health technology assessment (HTA) in healthcare, responds to the ICER 2023 Value Assessment Framework. While IVI appreciates ICER's efforts to improve patient engagement through initiatives like the Patient [...]
Alexandria, VA – September 28, 2023 – The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of health technology assessment (HTA) in healthcare, today released a new report, "Fulfilling the Promise of Equity in Value-Based Care: A Focus on Power, People, and Processes in Health [...]
Alexandria, VA – September 20, 2023 – The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of health technology assessment (HTA) in healthcare, today announced the top three winners of the Valuing Innovation Project (VIP) Call for Papers. The goal of the Call for Papers [...]
Alexandria, VA – August 29, 2023 – The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of health technology assessment in health care, today issued a statement in response to the Centers for Medicare and Medicaid Services’ (CMS) announcement of the first prescription drugs selected for price negotiations under the [...]
By Jason Spangler, MD, MPH, FACPM (CEO, Innovation and Value Initiative) In March, the Centers for Medicare and Medicaid Services (CMS) released draft guidance for its implementation of the Drug Price Negotiation Program (DPNP), a key component of the Inflation Reduction Act (IRA). This release and its associated comment period sparked far-ranging debate and [...]
Tim Lai is a graduate student at the Auburn University Harrison College of Pharmacy's Department of Health Outcomes Research and Policy, and the first recipient of the newly created fellowship for graduate students by the college and the Innovation and Value Initiative (IVI). Tim, thank you for taking the time to speak with us. [...]
Alexandria, VA – July 13, 2023 – The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of health technology assessment (HTA) in healthcare, today announced the release of its 2022 Annual Report. The 2022 Annual Report highlights IVI's key milestones and significant accomplishments across all [...]
IVI submitted comments on the ICER 2023 Value Assessment Framework. We appreciate the opportunity to provide comments on this important issue. In revising its value assessment framework, IVI recommends that ICER make modifications related to proposed methodological changes, patient engagement strategies, and methods for handling data gaps to increase equity within health technology assessment. [...]
Alexandria, VA – July 11, 2023 – The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of health technology assessment (HTA) in healthcare, submitted comments on the U.S. Food and Drug Administration's (FDA) Patient-Focused Drug Development: Incorporating Clinical Outcome Assessments into Endpoints for Regulatory Decision-Making [...]
